Published in J Clin Invest on June 01, 1987
Role of immunoglobulin G in platelet aggregation by viridans group streptococci. Infect Immun (1988) 0.91
Use of protein A-bearing staphylococci for the immunoprecipitation and isolation of antigens from cells. Methods Enzymol (1981) 5.03
Structural Aspects and Heterogeneity of Immunoglobulin Fc Receptors. Adv Immunol (1981) 3.56
Human platelet Fc receptor for immunoglobulin G. Identification as a 40,000-molecular-weight membrane protein shared by monocytes. J Clin Invest (1985) 1.82
Linkage of a membrane skeleton to integral membrane glycoproteins in human platelets. Identification of one of the glycoproteins as glycoprotein Ib. J Clin Invest (1985) 1.43
Retracted Target platelet antigen in homosexual men with immune thrombocytopenia. N Engl J Med (1985) 1.36
Platelet Fc receptor as a mechanism for Ag-Ab complex-induced platelet injury. Thromb Diath Haemorrh (1973) 1.25
Affinity isolation and characterization of immunoglobulin G Fc fragment-binding glycoprotein from human blood platelets. J Biol Chem (1979) 1.23
Structural analysis of human platelet membrane glycoprotein I complex. Proc Natl Acad Sci U S A (1979) 1.18
Platelet membrane glycoprotein IIIa contains target antigens that bind anti-platelet antibodies in immune thrombocytopenias. J Clin Invest (1984) 1.17
Hereditary giant platelet syndrome. Absence of collagen-induced coagulant activity and deficiency of factor-XI binding to platelets. Br J Haematol (1975) 1.16
Comparison of various tests for Fc receptors on different human lymphocyte sub populations. Clin Exp Immunol (1979) 1.10
Characterization of the IgG-Fc receptor on human platelets. Blood (1982) 1.09
Interaction of platelet membrane receptors with von Willebrand factor, ristocetin, and the Fc region of immunoglobulin G. J Clin Invest (1978) 1.03
Further studies of the human platelet receptor for quinine- and quinine-dependent antibodies. J Immunol (1981) 1.00
Dissociation of the receptor for immunoglobulin E in mild detergents. Biochemistry (1985) 0.97
Human peritoneal macrophages possess two populations of IgG Fc receptors. Cell Immunol (1984) 0.89
Acquired Bernard-Soulier syndrome. Evidence for the role of a 210,000-molecular weight protein in the interaction of platelets with von Willebrand factor. J Clin Invest (1985) 0.87
Platelet Fc receptor. Increased expression in myeloproliferative disease. J Clin Invest (1981) 0.84
The effect of pretreatment of human or rabbit platelets with chymotrypsin on their responses to human fibrinogen and aggregating agents. Blood (1979) 0.84
Synergistic platelet activation by aggregates of IgG and the phospholipid platelet-activating factor 1-O-alkyl-2-acetyl-SN-glycero-3-phosphorylcholine. J Clin Immunol (1986) 0.82
Platelets deficient in glycoprotein I have normal Fc receptor expression. Br J Haematol (1984) 0.82
The receptor for immunoglobulin E: taking it apart - putting it back together. Carl Prausnitz Memorial Lecture. Monogr Allergy (1983) 0.81
Anti-VEGF antibody treatment of glioblastoma prolongs survival but results in increased vascular cooption. Neoplasia (2001) 4.22
A platelet alpha-granule membrane protein (GMP-140) is expressed on the plasma membrane after activation. J Cell Biol (1985) 3.02
Failure of the International Normalized Ratio to generate consistent results within a local medical community. Am J Clin Pathol (1993) 2.81
Detection and sequence of mutations in the factor VIII gene of haemophiliacs. Nature (1985) 2.30
Prothrombin is activated on vascular endothelial cells by factor Xa and calcium. Proc Natl Acad Sci U S A (1983) 2.06
Redistribution of alpha-granules and their contents in thrombin-stimulated platelets. J Cell Biol (1984) 2.06
Reverse biochemistry: use of macromolecular protease inhibitors to dissect complex biological processes and identify a membrane-type serine protease in epithelial cancer and normal tissue. Proc Natl Acad Sci U S A (1999) 2.01
Immunological changes in patient with systemic lupus erythematosus treated with topical dinitrochlorobenzene. Lancet (1995) 1.92
Prevention of metastasis by inhibition of the urokinase receptor. Proc Natl Acad Sci U S A (1993) 1.82
Vascular endothelial growth factor and basic fibroblast growth factor urine levels as predictors of outcome in hormone-refractory prostate cancer patients: a cancer and leukemia group B study. Cancer Res (2001) 1.71
Heterogeneity of human whole blood platelet subpopulations. I. Relationship between buoyant density, cell volume, and ultrastructure. Blood (1977) 1.69
Characterization of a human Kaposi's sarcoma cell line that induces angiogenic tumors in animals. AIDS (1994) 1.68
Characterization of the effects of cultured vascular cells on the activation of blood coagulation. Blood (1983) 1.63
Development of antithrombin antibodies following surgery in patients with prosthetic cardiac valves. Blood (1988) 1.60
Identification of a missense mutation in the factor VIII gene of a mild hemophiliac. Science (1986) 1.60
An AIDS-related cytotoxic autoantibody reacts with a specific antigen on stimulated CD4+ T cells. Nature (1987) 1.57
The measurement of thrombin in clotting blood by radioimmunoassay. J Clin Invest (1976) 1.56
HIV contamination of poliovaccines. Lancet (1994) 1.50
Thrombin-cellular interactions. Ann N Y Acad Sci (1986) 1.47
The platelet fibrinogen receptor: an immunogold-surface replica study of agonist-induced ligand binding and receptor clustering. J Cell Biol (1987) 1.47
Polio vaccines and the origin of AIDS. Med Hypotheses (1994) 1.45
Urokinase receptor antagonists inhibit angiogenesis and primary tumor growth in syngeneic mice. Cancer Res (1996) 1.45
Circulating immune complexes in patients with acquired immune deficiency syndrome contain the AIDS-associated retrovirus. Clin Immunol Immunopathol (1986) 1.44
The pharmacokinetics of 8-methoxypsoralen following i.v. administration in humans. Br J Clin Pharmacol (1995) 1.44
The frequency of lupus anticoagulant in systemic lupus erythematosus. A study of sixty consecutive patients by activated partial thromboplastin time, Russell viper venom time, and anticardiolipin antibody level. Ann Intern Med (1987) 1.42
Bridging the gap: human diploid cell strains and the origin of AIDS. J Theor Biol (2000) 1.41
Polio vaccines and the origin of AIDS. Res Virol (1993) 1.40
Anaphylactoid reactions to vascular graft material presenting with vasodilation and subsequent disseminated intravascular coagulation. Anesthesiology (1989) 1.39
Biogenesis of the platelet receptor for fibrinogen: evidence for separate precursors for glycoproteins IIb and IIIa. Proc Natl Acad Sci U S A (1986) 1.37
Retracted Target platelet antigen in homosexual men with immune thrombocytopenia. N Engl J Med (1985) 1.36
The urokinase receptor is expressed in invasive breast cancer but not in normal breast tissue. Cancer Res (1994) 1.36
Vascular endothelial growth factor promotes tumor dissemination by a mechanism distinct from its effect on primary tumor growth. Cancer Res (1996) 1.35
Platelet glycoprotein IIb. Chromosomal localization and tissue expression. J Clin Invest (1987) 1.31
Cloning of glycoprotein IIIa cDNA from human erythroleukemia cells and localization of the gene to chromosome 17. Blood (1988) 1.27
Humoral response to SIV/SMM infection in macaque and mangabey monkeys. J Acquir Immune Defic Syndr (1990) 1.25
Endocytosis of fibrinogen into megakaryocyte and platelet alpha-granules is mediated by alpha IIb beta 3 (glycoprotein IIb-IIIa) Blood (1993) 1.25
Heterogeneity of human whole blood platelet subpopulations. II. Use of a subhuman primate model to analyze the relationship between density and platelet age. Blood (1978) 1.23
Co-expression of urokinase, urokinase receptor and PAI-1 is necessary for optimum invasiveness of cultured lung cancer cells. Int J Cancer (1995) 1.23
Origin of AIDS. Lancet (1992) 1.20
Immunohistochemical localization of membrane and alpha-granule proteins in human megakaryocytes: application to plastic-embedded bone marrow biopsy specimens. Blood (1986) 1.19
Effects of urokinase receptor occupancy on plasmin generation and proteolysis of basement membrane by human tumor cells. Blood (1991) 1.17
Incorporation of a circulating protein into megakaryocyte and platelet granules. Proc Natl Acad Sci U S A (1987) 1.14
Corrected count increment and percent platelet recovery as measures of posttransfusion platelet response: problems and a solution. Transfusion (1999) 1.13
Blood lead concentrations in a remote Himalayan population. Science (1980) 1.13
Characteristics of the membrane defect in the hereditary stomatocytosis syndrome. Blood (1975) 1.11
Medical uses of vitamin E. N Engl J Med (1983) 1.11
The zymogen forms of blood coagulation factor XIII bind specifically to fibrinogen. J Biol Chem (1982) 1.10
Photochemical inactivation of viruses and bacteria in platelet concentrates by use of a novel psoralen and long-wavelength ultraviolet light. Transfusion (1997) 1.08
Dinitrochlorobenzene and Chagas' disease. Lancet (1995) 1.08
Physical linkage of the genes for platelet membrane glycoproteins IIb and IIIa. Proc Natl Acad Sci U S A (1988) 1.08
"In silico experiments"--yes, but the great western cowboy "random chance" is still alive. Fertil Steril (2001) 1.08
The binding of human and bovine thrombin to human platelets. Blood (1976) 1.08
"Buffalo humps" associated with protease inhibitors. Ann Intern Med (1999) 1.08
The perturbation of thrombin binding to human platelets by anions. J Clin Invest (1975) 1.07
CD8 T-cell response to antiretroviral therapy. J Acquir Immune Defic Syndr Hum Retrovirol (1997) 1.07
Optimal techniques for the immunocytochemical demonstration of beta-thromboglobulin, platelet factor 4, and fibrinogen in the alpha granules of unstimulated platelets. Histochem J (1984) 1.06
Incorporation of intravenously injected albumin, immunoglobulin G, and fibrinogen in guinea pig megakaryocyte granules. J Clin Invest (1989) 1.06
Thrombopoietin levels in patients with cirrhosis before and after orthotopic liver transplantation. Ann Intern Med (1997) 1.03
Antinuclear antibody, lupus anticoagulant, and anticardiolipin antibody in women with idiopathic habitual abortion. A controlled, prospective study of forty-four women. Arthritis Rheum (1987) 1.03
Relationship between secretion of platelet Factor 4 and thrombin generation during in vitro blood clotting. J Clin Invest (1980) 1.02
Platelet-associated immunoglobulin, platelet size, and the effect of splenectomy in the Wiskott-Aldrich syndrome. Blood (1985) 1.00
Splenectomy in the management of the thrombocytopenia of the Wiskott-Aldrich syndrome. N Engl J Med (1980) 0.99
AIDS virus infection and autoimmunity: a perspective of the clinical, immunological, and molecular origins of the autoallergic pathologies associated with HIV disease. Clin Immunol Immunopathol (1991) 0.99
Identification of an abnormal gene for the GPIIIa subunit of the platelet fibrinogen receptor resulting in Glanzmann's thrombasthenia. Blood (1990) 0.98
Hematologic and immunologic abnormalities in anorexia nervosa. South Med J (1983) 0.98
Monoamine oxidase activity in different density gradient fractions of human platelets. Psychopharmacology (Berl) (1978) 0.97
Photochemical inactivation of pathogenic bacteria in human platelet concentrates. Blood (1994) 0.96
Regulation of thrombopoiesis: effects of the degree of thrombocytopenia on megakaryocyte ploidy and platelet volume. Blood (1987) 0.96
Photochemical inactivation of bacteria and HIV in buffy-coat-derived platelet concentrates under conditions that preserve in vitro platelet function. Vox Sang (2000) 0.95
Relation of circulating levels of human immunodeficiency virus (HIV) antigen, antibody to p24, and HIV-containing immune complexes in HIV-infected patients. J Infect Dis (1988) 0.95
Prolonged CD4+ lymphocytopenia and thrombocytopenia in a chimpanzee persistently infected with human immunodeficiency virus type 1. J Infect Dis (1991) 0.95
Functional characteristics of S-59 photochemically treated platelet concentrates derived from buffy coats. Vox Sang (2000) 0.95
Prevention of transfusion-associated graft-versus-host disease by photochemical treatment. Blood (1999) 0.95
Thrombin generation and secretion of platelet Factor 4 during blood clotting. J Clin Invest (1978) 0.94
Activation of plasminogen by tissue plasminogen activator on normal and thrombasthenic platelets: effects on surface proteins and platelet aggregation. Blood (1986) 0.94
The number of receptors for factor VII correlates with the ability of cultured cells to initiate coagulation. Blood (1984) 0.94
Immunohistochemical localization of the plasminogen activator inhibitor-1 in breast cancer. Int J Cancer (1995) 0.94
Topographic distribution of a granule membrane protein (GMP-140) that is expressed on the platelet surface after activation: an immunogold-surface replica study. Blood Cells (1986) 0.93
Internalization and degradation of thrombin and up regulation of thrombin-binding sites in corneal endothelial cells. J Biol Chem (1981) 0.92
Neuraminidase-induced thrombocytopenia in mice: effects on thrombopoiesis. J Cell Physiol (1991) 0.92
Use of 8-methoxypsoralen and long-wavelength ultraviolet radiation for decontamination of platelet concentrates. Blood (1989) 0.91
Heterogeneity of human whole blood platelet subpopulations. III. Density-dependent differences in subcellular constituents. Blood (1984) 0.91
Specific binding of blood coagulation factor XIIIa to thrombin-stimulated platelets. J Biol Chem (1984) 0.90
Hematologic malignancy in sickle cell disease: report of four cases and review of the literature. Am J Hematol (1986) 0.90
Inactivation of leukocytes in platelet concentrates by photochemical treatment with psoralen plus UVA. Blood (1998) 0.90
Kistrin, an integrin antagonist, blocks endocytosis of fibrinogen into guinea pig megakaryocyte and platelet alpha-granules. J Clin Invest (1993) 0.89
Human platelets and megakaryocytes contain alternately spliced glycoprotein IIb mRNAs. J Biol Chem (1990) 0.89
The isolation of vascular endothelial cell lines with altered cell surface and platelet-binding properties. Cell (1978) 0.89
The molecular mechanism of the inherited phosphofructokinase deficiency associated with hemolysis and myopathy. Blood (1980) 0.88
Acquired Bernard-Soulier syndrome. Evidence for the role of a 210,000-molecular weight protein in the interaction of platelets with von Willebrand factor. J Clin Invest (1985) 0.87
Case report: successful use of antifibrinolytic therapy in acquired factor VIII deficiency. Am J Med Sci (1992) 0.87
The transglutaminase in vascular cells and tissues could provide an alternate pathway for fibrin stabilization. Blood (1987) 0.87